Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
IAIntegra LifeSciences Holdings Corporation logo

Integra LifeSciences Holdings Corporation (IART)

NASDAQ Global Select · Currency in USD
$11.91 ▼ -0.42 (-3.37%)
At close: Oct 23, 4:00 PM ET. Market closed.
$11.91 ▲ +0.00 (+0.00%)
After hours: Oct 23, 7:30 PM ET

Summary

Previous Close
$12.33
Open
$12.12
Day's Range
$11.82 – $12.40
52 Week Range
$8.70 – $20.49
Volume
1,212,688
Avg. Volume
967,909
Market Cap
$926.27M
Beta (5Y Monthly)
1.21
PE Ratio (TTM)
70.98
EPS (TTM)
$0.17
Earnings Date
Feb 25, 2027
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$16.80

Profile: Integra LifeSciences Holdings Corporation

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
4,427
CEO
Stuart Essig

Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue Technologies.

Earnings

Next report: Thu, Feb 25, 2027
EPS estimate $0.69 · Revenue est. $422.37M
DateEst.Actual
Oct 21, 2026$0.56$0.59Beat
Jul 29, 2026$0.48$0.56Beat
May 5, 2026$0.41$0.54Beat
Feb 26, 2026$0.79$0.83Beat
Oct 30, 2025$0.43$0.54Beat
Jul 31, 2025$0.43$0.45Beat

Analyst view

Consensus price target
$16.80 ▲ +41.1%
Range $13.00 – $25.00
Rating: Buy
Buy 43% · Hold 43% · Sell 14%

Get free alerts on IART and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.